LOGICBIO THERAPEUTICS INC - COM (LOGC)

CUSIP: 54142F102

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM
Total 13F shares
10,734,910
Share change
-762,527
Total reported value
$97,586,355
Price per share
$9.08
Number of holders
47
Value change
-$6,435,679
Number of buys
23
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 54142F102?
CUSIP 54142F102 identifies LOGC - LOGICBIO THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOGICBIO THERAPEUTICS INC - COM (LOGC) as of Q3 2020

As of 30 Sep 2020, LOGICBIO THERAPEUTICS INC - COM (LOGC) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,734,910 shares. The largest 10 holders included ORBIMED ADVISORS LLC, SAMLYN CAPITAL, LLC, BlackRock Inc., FRANKLIN RESOURCES INC, Lion Point Capital, LP, VANGUARD GROUP INC, JPMORGAN CHASE & CO, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP. This page lists 47 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.